|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.337
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.325
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.304
|
|
|
|
cellular response to interleukin 4
|
GO:0071353 |
21 |
0.298
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.286
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.274
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.272
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.241
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.240
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.227
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.215
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.215
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.209
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.200
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.198
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.194
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.177
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.175
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.167
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.154
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.152
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.151
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.143
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.141
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.133
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.126
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.124
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.121
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.120
|
|
|
|
translation
|
GO:0006412 |
93 |
0.117
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.115
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.112
|
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.111
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.106
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.105
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.102
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.099
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.099
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.095
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.090
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.090
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.089
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.088
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.088
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.086
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.085
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.083
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.083
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.083
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.081
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.080
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.078
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.072
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.071
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.071
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.070
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.068
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.068
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.068
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.066
|
|
|
|
retina homeostasis
|
GO:0001895 |
23 |
0.065
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.065
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.064
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.063
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.063
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.062
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.061
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.060
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.059
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.059
|
|
|
|
translational elongation
|
GO:0006414 |
12 |
0.059
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.058
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.058
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.057
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.057
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.057
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.056
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.056
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.056
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.054
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.054
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.054
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.054
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.053
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.052
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.052
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.051
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.051
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.051
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.050
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.048
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.047
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.047
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.043
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.043
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.043
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.043
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.042
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.042
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.042
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.042
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.041
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.040
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.040
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.040
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.040
|
|
|
|
centrosome cycle
|
GO:0007098 |
23 |
0.038
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.038
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.038
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.038
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.037
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.036
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.036
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.035
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.035
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.035
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.034
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.034
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.034
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.033
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.033
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.033
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.033
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.032
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.032
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.032
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.031
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.031
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.031
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.031
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
response to amine
|
GO:0014075 |
16 |
0.030
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.029
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.029
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.029
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.029
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.028
|
|
|
|
nuclear export
|
GO:0051168 |
34 |
0.028
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.028
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.027
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.027
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.027
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.026
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.026
|
Human |
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.026
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.025
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.025
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.025
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.025
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.025
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.025
|
|
|
|
ketone catabolic process
|
GO:0042182 |
3 |
0.025
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.024
|
|
|
|
translational initiation
|
GO:0006413 |
24 |
0.024
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.024
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.024
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.024
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.024
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.023
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.023
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.023
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.023
|
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.022
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.022
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.022
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.022
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
Human |
|
|
cofactor transport
|
GO:0051181 |
4 |
0.022
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.021
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.021
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.021
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.020
|
|
|
|
purine nucleoside biosynthetic process
|
GO:0042451 |
19 |
0.020
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.020
|
|
|
|
regulation of translational elongation
|
GO:0006448 |
4 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.020
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.019
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.019
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.019
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.019
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.019
|
|
|
|
regulation of protein import into nucleus translocation
|
GO:0033158 |
2 |
0.019
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.019
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.018
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.018
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.018
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.018
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.018
|
|
|
|
4 hydroxyproline metabolic process
|
GO:0019471 |
5 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.018
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.018
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.017
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.017
|
Human |
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.017
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.016
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.016
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.016
|
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.016
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.016
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.016
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
21 |
0.015
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.015
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.015
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.015
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.015
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.015
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.015
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.015
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.015
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.015
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.015
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.014
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.014
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.014
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.014
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.014
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.014
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.014
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.014
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.014
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.014
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.014
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.014
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.013
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
19 |
0.013
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.013
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.013
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.013
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.013
|
|
|
|
water soluble vitamin biosynthetic process
|
GO:0042364 |
3 |
0.013
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.013
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.013
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.012
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.012
|
|
|
|
glycogen biosynthetic process
|
GO:0005978 |
14 |
0.012
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.012
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.012
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.012
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.012
|
|
|
|
ribosomal large subunit assembly
|
GO:0000027 |
2 |
0.012
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.012
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.012
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.012
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.012
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.012
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.012
|
|
|
|
camp catabolic process
|
GO:0006198 |
4 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
21 |
0.012
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.012
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.012
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.012
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.012
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.012
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.011
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.011
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.011
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.011
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.011
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.011
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.011
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.011
|
|
|
|
nucleic acid transport
|
GO:0050657 |
18 |
0.011
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.011
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.011
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.011
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.011
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.011
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.011
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.011
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
20 |
0.011
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.011
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.011
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.011
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.010
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.010
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.010
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.010
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.010
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.010
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.010
|
|
|
|
adenine nucleotide transport
|
GO:0051503 |
2 |
0.010
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.010
|
|
|
|
regulation of phosphoprotein phosphatase activity
|
GO:0043666 |
3 |
0.010
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.010
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.010
|
|